Latest news
ELTX Stock Heads For Worst Day Ever — Elicio Therapeutics' Pancreatic Cancer Data Disappoints - StocktwitsStocktwits · Fri, 07 Aug 2026 05:23:20 GMTTango hopes it takes two: vopimetostat combos build on Revolution's pancreatic cancer breakthrough - FirstWord PHARMAFirstWord PHARMA · Thu, 06 Aug 2026 14:48:37 GMTFDA Accepts daraxonrasib Application for RAS-Mutant Pancreatic Cancer - The Clinical Trial VanguardThe Clinical Trial Vanguard · Thu, 06 Aug 2026 06:43:58 GMTFDA fast-tracks experimental medication for rare pancreatic cancer - Rare Cancer NewsRare Cancer News · Wed, 05 Aug 2026 13:56:32 GMT